Single-cell transcriptomics of NRAS-mutated melanoma transitioning to drug resistance reveals P2RX7 as an indicator of early drug response.
第一作者:
Tijana,Randic
第一单位:
Department of Life Sciences and Medicine (DLSM), University of Luxembourg, 6, Avenue du Swing, 4367 Belvaux, Luxembourg.
作者:
医学主题词
人类(Humans);蛋白激酶抑制剂(Protein Kinase Inhibitors);抗药性, 肿瘤(Drug Resistance, Neoplasm);细胞系, 肿瘤(Cell Line, Tumor);黑色素瘤(Melanoma);突变(Mutation);原癌基因蛋白质B-raf(Proto-Oncogene Proteins B-raf);受体, 嘌呤能P2X7(Receptors, Purinergic P2X7);膜蛋白质类(Membrane Proteins);GTP磷酸水解酶类(GTP Phosphohydrolases)
DOI
10.1016/j.celrep.2023.112696
PMID
37379213
发布时间
2023-07-31
- 浏览2
Cell reports
112696页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



